Scientists Propose New Mechanism Driving Alzheimer's Disease

Science & Tech 15:40 05.10.2022
Amyloid-beta plaques have long been linked to Alzheimer's disease, with some scientists theorizing that the plaques actually cause the degenerative brain disease.
 
But a new study suggests that the plaques are actually a symptom of what's going on in the brain, rather than the cause of Alzheimer's.
 
Instead, decreasing levels of the "normal," water-soluble form of amyloid-beta is the real culprit behind Alzheimer's, a research team argues in the Journal of Alzheimer's Disease.
 
"The paradox is that so many of us accrue plaques in our brains as we age, and yet so few of us with plaques go on to develop dementia," said lead researcher Dr. Alberto Espay. He's director and endowed chair of the Center for Parkinson's Disease and Movement Disorders at the University of Cincinnati Neuroscience Institute.
 
"Yet the plaques remain the center of our attention as it relates to biomarker development and therapeutic strategies," Espay said in a university news release.
 
The team's previous research had found that regardless of plaque buildup in the brain, people with high levels of soluble amyloid-beta kept their brain health. On the other hand, those with low levels of the protein were more likely to have cognitive impairment.
 
The researchers think soluble amyloid-beta levels decrease because the normal protein, exposed to stressors, starts transforming into abnormal amyloid plaques.
 
For this study, Espay and his team focused on amyloid-beta levels in a specific group of patients who carry mutations that predict they'd have more amyloid plaques in their brains -- and therefore should be more likely to develop Alzheimer's disease.
 
However, this group wound up having the same Alzheimer's risk as the general population. (Click here for Alzheimer's risk factors).
 
"What we found was that individuals already accumulating plaques in their brains who are able to generate high levels of soluble amyloid-beta have a lower risk of evolving into dementia over a three-year span," Espay said.
 
Folks carrying a baseline level of soluble amyloid-beta can remain cognitively normal, regardless of the amount of amyloid plaques in their brains, researchers found.
 
These results jibe with previous clinical trials that showed that drugs effective in reducing amyloid plaques in the brain failed to slow the progression of Alzheimer's, researchers said. Earlier studies also have shown that reducing levels of soluble amyloid-beta can cause worse outcomes for Alzheimer's patients.
 
Next, the researchers plan to test whether increasing levels of soluble amyloid-beta in the brain could be a beneficial therapy for Alzheimer's.
IEPF issued a statement regarding Azerbaijani children at the UN Human Rights Council

News line

Protest Held in London Backing Pro-Palestine March Organizers Accused of Offences
11:15 08.07.2025
Japan to make diplomatic efforts to ensure implementation of Israel-Iran ceasefire: Top diplomat
11:00 08.07.2025
Trump Holds Talks with Netanyahu at the White House
10:45 08.07.2025
Trump says US has 'scheduled Iran talks'
10:30 08.07.2025
Trump says US will supply weapons to Ukraine
10:15 08.07.2025
Priorities of Azerbaijan's international development policy discussed
10:00 08.07.2025
US to impose 25% duties on imports from Kazakhstan from August
09:45 08.07.2025
Plans for border delimitation, demarcation with Armenia discussed in Baku
09:30 08.07.2025
Israel wants to coordinate with US on possibility of new strikes on Iran
09:15 08.07.2025
Netanyahu nominates Trump for Nobel Peace Prize
09:00 08.07.2025
Geno rejects signing of 38-year-old Jamie Vardy
21:00 07.07.2025
Gaza death toll passes 57,500 as Israeli attacks continue unabated
20:45 07.07.2025
Russian emergencies minister arrives in Baku
20:25 07.07.2025
Trump due to meet Netanyahu at White House
20:15 07.07.2025
Russia attacks recruitment centers in Ukraine's Kharkiv, Zaporizhzhia
20:00 07.07.2025
Pezeshkian says Israel attempted assassination against him
19:45 07.07.2025
Iran has military capability to strike Israel daily for 2 years, IRGC adviser says
19:20 07.07.2025
US envoy says ‘satisfied’ with Lebanese response on roadmap to disarm Hezbollah
19:00 07.07.2025
Peskov: Russia, Azerbaijan should remain close partners, allies
18:45 07.07.2025
The Gulf Observer: Armenians' destruction of Azerbaijan's cultural heritage - vandalism against all humanity
18:30 07.07.2025
Official: Nearly 1M foreigners arrived in Azerbaijan in 5 months of 2025
18:15 07.07.2025
Chief of General Staff of Azerbaijan Army visits Saudi Arabia
18:00 07.07.2025
Israeli PM approved Yemen airstrikes during his flight to US
17:45 07.07.2025
Expert: ECO Summit in Khankendi confirmed member countries' desire for inclusive, multipolar world
17:30 07.07.2025
AZAL introduces new online service
17:15 07.07.2025
Poland imposes checks on German and Lithuanian borders amid migration fears
17:00 07.07.2025
Saudi Arabia raises August oil prices for Asia, Europe buyers
16:45 07.07.2025
EU Reporter: Karabakh region became platform for int'l forums
16:15 07.07.2025
Georgian PM says direct foreign interference in democratic elections failed
16:00 07.07.2025
Typhoon Danas kills two in Taiwan, injures over 500
15:45 07.07.2025
'Coalition of the Willing' may fall apart over Starmer-Macron conflict
15:30 07.07.2025
Former Adjara head hospitalized with gunshot wound in Georgia
15:15 07.07.2025
Scientists reveal how caffeine slows down aging
15:00 07.07.2025
Thailand to offer US more trade concessions to avert 36% tariff
14:45 07.07.2025
Putin dismisses transport minister
14:30 07.07.2025
Israel carries out strikes on Houthi-controlled power station, ports across Yemen
14:15 07.07.2025
UK to name Iran as one of its biggest threats
14:00 07.07.2025
Armenia rejects possibility of using country's territory for military purposes
13:45 07.07.2025
Mexico defeats US for second consecutive Gold Cup title
13:30 07.07.2025
Iranian FM calls attacks on Iran's nuclear facilities flagrant violation of NPT
13:15 07.07.2025
Hamısı